VI Congressonazionale della Società italiana dell'osteoporosi, del metabolismo minerale e delle malattie dello scheletro (SIOMMMS) Pisa, November 22-25, 2006 by CIC , Edizioni internazionali
211
Vol. III September-December 2006 N. 3
ABSTRACTS
VI CONGRESSO NAZIONALE DELLA SOCIETÀ ITALIANA
DELL’OSTEOPOROSI, DEL METABOLISMO MINERALE
E DELLE MALATTIE DELLO SCHELETRO
(SIOMMMS)
Pisa, November 22-25, 2006
Contents
A Message from the SIOMMMS President ..................................................................................................................... 227
Lectures, Symposia, Seminars
A MULTICENTER, DOUBLE-BLIND, BETWEEN PATIENT, PLACEBO CONTROLLED STUDY, TO ASSESS THE EFFICACY 
AND TOLERABILITY OF DIFFERENT TREATMENT REGIMENS OF NERIDRONATE AMPOULES, 
ADMINISTERED BY INTRAMUSCULAR ROUTE TO WOMEN AFFECTED BY POSTMENOPAUSAL OSTEOPOROSIS
S. Adami, V. Braga, V. Lo Cascio, F. Bertoldo, G. Realdi, L. Sartori, O. Di Munno, A. Delle Sedie, P. Filipponi, S. Cristallini, 
C. Marcocci, E. Vignali, R. Marcologongo, B. Frediani, E. Palummeri, A. Barone, C.E. Fiore, P. Pennisi, D. Costi............................................ 233
LIMITATIONS OF CURRENT THERAPIES: NEW PERSPECTIVE AND UPDATE ON TERIPARATIDE
S. Adami ..................................................................................................................................................................................................................... 235
TREATMENT OF NEOPLASTIC HYPERCALCEMIA
R. Berardi, C. Pierantoni, M. Scartozzi, S. Cascinu .................................................................................................................................................. 236
OSTEOPOROSIS: A LOGICAL EVOLUTION IN THE TREATMENT
F. Bertoldo ................................................................................................................................................................................................................. 237
OSTEOMALACIA
M. Bevilacqua, M. Mazzantini ................................................................................................................................................................................... 240
ROLE OF ADHERENCE IN THE ACHIEVEMENT OF TREATMENT OUTCOMES IN OSTEOPOROSIS
G. Bianchi .................................................................................................................................................................................................................. 241
BUILDING NEW BONE: A NEW PARADIGM IN OSTEOPOROSIS
D.M. Black ................................................................................................................................................................................................................. 243
RENAL OSTEODISTROPHY: NEW THERAPEUTIC OPTIONS
D. Brancaccio ............................................................................................................................................................................................................ 245
PERCUTANEOUS VERTEBRAL CONSOLIDATION BY MEANS OF VERTEBROPLASTY AND KYPHOPLASTY: 
NEW MINI-INVASIVE THERAPEUTIC STRATEGIES FOR VERTEBRAL COLLAPSE
P. Carpeggiani, F. Calvosa ....................................................................................................................................................................................... 246
CLINICAL CASES
IN MINERAL AND BONE METABOLISM
DIAGNOSTIC APPROACH TO HYPERCALCIURIA
R. Caudarella, C.M. Francucci.................................................................................................................................................................................. 252
PRIMARY HYPERPARATHYROIDISM 
F. Cetani, A. Scillitani................................................................................................................................................................................................ 253
PATHOGENETIC MECHANISMS OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
A. Dovio ..................................................................................................................................................................................................................... 254
PAGET’S DISEASE OF BONE
A. Falchetti................................................................................................................................................................................................................. 256
INTERTROCHANTERIC FRACTURES. SURGICAL TREATMENT OF BIPOLAR HIP REPLACEMENT 
OR TOTAL HIP REPLACEMENT IN OSTEOPOROTIC PATIENTS
A. Faldini ................................................................................................................................................................................................................... 258
TUMOR INDUCED OSTEOMALACIA 
P. Filipponi ................................................................................................................................................................................................................ 264
HOW TO REBALANCE BONE TURNOVER IN FAVOUR OF FORMATION?
C. Erio Fiore, P. Pennisi............................................................................................................................................................................................ 265
CLODRONATE: THE PRESENT AND THE FUTURE 
B. Frediani ................................................................................................................................................................................................................. 267
BISPHOSPHONATES AND OSTEONECROSIS OF THE JAW 
M. Gabriele, L. Dalle Carbonare .............................................................................................................................................................................. 269
CLINICAL APPLICATIONS OF BONE DENSITOMETRY
D. Gatti, C.V. Albanese.............................................................................................................................................................................................. 271
NEW DIRECTION IN THE USE OF HORMONE REPLACEMENT THERAPY FOR THE PREVENTION 
OF POSTMENOPAUSAL OSTEOPOROSIS
A.R. Genazzani ........................................................................................................................................................................................................... 275
OSTEOPOROSIS TREATMENT IN CLINICAL PRACTICE
S. Giannini ................................................................................................................................................................................................................. 276
A PREMENOPAUSAL WOMAN WITH LOW BMD: A CLINICAL CASE
G. Girasole, A. Del Puente ........................................................................................................................................................................................ 278
OSTEOPOROSIS IN MEN
S. Gonnelli ................................................................................................................................................................................................................. 279
PITFALLS IN BMD MEASUREMENTS
G. Guglielmi, E. Vignali............................................................................................................................................................................................. 281
THE PATIENT WITH TWO OR MORE FRAGILITY FRACTURES: 
PATIENT EVALUATION, STRATEGIES FOR PHARMACOLOGICAL MANAGEMENT AND FOLLOW-UP
G. Isaia....................................................................................................................................................................................................................... 282
TARGETING TREATMENT OF OSTEOPOROSIS BY FRACTURE RISK
J.A. Kanis ................................................................................................................................................................................................................... 283
CLINICAL UTILITY OF THE MARKERS OF BONE TURNOVER
G. Luisetto, L. Moro................................................................................................................................................................................................... 284
DERANGEMENTS OF CALCIUM AND PHOSPHATE METABOLISM AND PREDICTORS OF MORTALITY 
IN CHRONIC KIDNEY DISEASES
F. Malberti ................................................................................................................................................................................................................. 285
ENDOCRINE OSTEOPOROSES
C. Marcocci................................................................................................................................................................................................................ 286
MOLECULAR DIAGNOSIS OF THE METABOLIC BONE DISEASES
L. Masi, S. Migliaccio ................................................................................................................................................................................................ 287
EXTRAOSSEOUS MINERALIZATION IN UREMIA
S. Mazzaferro ............................................................................................................................................................................................................. 289
PREVENTION OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN YOUNG PEOPLE
G. Minisola, L. Di Matteo .......................................................................................................................................................................................... 291
212
PATHOPHYSIOLOGY OF HYPERCALCEMIA ASSOCIATED WITH MALIGNANCY
S. Minisola ................................................................................................................................................................................................................. 296
THE ROLE OF VITAMIN D IN THE TREATMENT OF OSTEOPOROSIS
S. Minisola ................................................................................................................................................................................................................. 297
ADVANCES IN UNDERSTANDING THE PATHOGENESIS OF RENAL OSTEODYSTROPHY
L.F. Morrone.............................................................................................................................................................................................................. 298
SEVERE OSTEOPOROSIS: EPIDEMIOLOGY AND LIMITS OF WHO DEFINITION 
R. Nuti ........................................................................................................................................................................................................................ 300
BONE TURNOVER IN PATIENTS WITH POST-MENOPAUSAL OSTEOPOROSIS: SUPPRESS OR REBALANCE 
R. Nuti ....................................................................................................................................................................................................................... 301
NUTRITION AND BONE GROWTH
R. Rizzoli .................................................................................................................................................................................................................... 303
RARE SKELETAL DISORDERS
M. Rossini, D. Trippi.................................................................................................................................................................................................. 304
ROLE OF PTH RECEPTOR IN BONE REMODELING
E. Schipani ................................................................................................................................................................................................................. 306
BROADENING THE EVIDENCE IN OSTEOPOROSIS: THE ROLE OF “REAL WORLD DATA”
S.L. Silverman ............................................................................................................................................................................................................ 307
TREATMENT EVOLUTION WITH BISPHOSPHONATES: OFFERING NEW OTPIONS TO PATIENTS
L. Sinigaglia, M. Varenna .......................................................................................................................................................................................... 308
MOLECULAR MECHANISMS OF BONE METASTASIS
A.M. Teti..................................................................................................................................................................................................................... 310
ALGODYSTROPHY
M. Varenna, L. Sinigaglia .......................................................................................................................................................................................... 311
Oral Communications and Posters
COMBINED EVALUATION OF PARAFIBROMIN IMMUNOSTAINING AND HRPT2 GENE ANALYSIS IN PARATHYROID 
ADENOMAS AND CARCINOMAS
E. Ambrogini, F. Cetani, P. Viacava, E. Pardi, G. Fanelli, A.G. Naccarato, S. Borsari, M. Lemmi, P. Berti, A. Pinchera, C. Marcocci .............. 315
CAREGIVER BURDEN AND FRACTURES IN DEMENTED ELDERLY SUBJECTS: 
PRELIMINARY RESULTS OF A CROSS-SECTIONAL STUDY
S. Andreani, S. Ercolani, E. Mariani, A. Mariani, P. Mecocci, D. Maggio .............................................................................................................. 316
IDENTIFICATION OF WOMEN FOR BONE DENSITOMETRY: ANALYSIS OF A LARGE GROUP OF WOMEN REFERRING 
FOR DUAL-ENERGY-X-RAY ABSORPTIOMETRY (DEXA) BY APPLYING A RISK ESTIMATION QUESTIONNAIRE
M.G. Aragno, L. Gianotti, R. Giuliano, F. Tassone, C. Fagliano, P. Carignano, A. Toselli, G. Borretta, A. Biggi................................................. 317
RALOXIFENE PREVENTS CANCELLOUS BONE QUALITATIVE DAMAGE DURING MENOPAUSE
P. Astazi ..................................................................................................................................................................................................................... 319
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON BONE METABOLISM IN POSTMENOPAUSAL WOMEN: 
A 2-YEAR RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
M. Atteritano, S. Mazzaferro, M.L. Cannata, A. Bitto, A. Gaudio, R. D’Anna, C. Lubrano, F. Squadrito, N. Frisina ............................................ 320
EFFICACY AND ROLE OF TERIPARATIDE DURING POST MENOPAUSAL OP TREATMENT IN WOMEN NON RESPONDERS 
TO COMMON TREATMENT WITH BISPHOSPHONATES 
D. Avila, G. Cusumano, G. Di Giovanni, C. Sferrazza, G.B. Rini ............................................................................................................................. 322
DIFFERENT FRAMESHIFT MUTATIONS OF MEN1 GENE IN TWO ITALIAN FAMILIES AFFECTED BY MULTIPLE ENDOCRINE 
NEOPLASIA TYPE 1
C. Banti, F. Cetani, M. Lemmi, E. Pardi, E. Ambrogini, A. Pucci, E. Vignali, A. Picone, G. Viccica, S. Borsari, P. Vitti, C. Marcocci ................ 323
EPIDEMIOLOGICAL SURVEY OF OSTEOPOROSIS IN A GENETIC ISOLATE OF OGLIASTRA AS A PREREQUISITE 
FOR IDENTIFICATION OF PREDISPOSING RISK FACTORS
G. Biino, L. Casula, F. de Terlizzi, M. Adamo, D. Serra, M. Cosso, G. Mancosu, M. Francavilla, G. Tuligi, F. Piras, A. Angius, M. Pirastu ...... 325
THE SIOMMMS 10 YR RISK ALGORITHM SCORE IN THE CLINICAL SETTING
A. Bonazza, R. Mameli ............................................................................................................................................................................................... 327
213
see page 216
GENETIC ANALYSIS OF MEN1 GENE IN AN ITALIAN KINDRED WITH FAMILIAL ISOLATED HYPERPARATHYROIDISM
S. Borsari, F. Cetani, M. Lemmi, E. Pardi, E. Ambrogini, M. Sculli, E. Vignali, A. Picone, C. Banti, G. Viccica, A. Pinchera, C. Marcocci ....... 329
ROLE OF OSTEOPROTEGERIN IN THE PATHOGENESIS OF THALASSEMIA INDUCED OSTEOPOROSIS
S. Bucchieri, F. De Nicola, N. Napoli, F. Giordano, F. Castello, G. Di Lorenzo, P. Mansueto, G. Di Fede, G.B. Rini ......................................... 330
THE USEFULNESS OF QUANTITATIVE ULTRASOUND IN MONITORING THE EFFECT OF TERIPARATIDE 
IN OSTEOPOROTIC WOMEN: A 2-YEAR STUDY
C. Caffarelli, A. Cadirni, K. Del Santo, S. Simoncioli, S. Salvadori, G. Martini, S. Gonnelli, R. Nuti ..................................................................... 332
AROMATASE INHIBITOR EXEMESTANE INCREASES BONE TURNOVER AND DECREASES BMD IN WOMEN 
WITH BREAST CANCER 
C. Caffarelli, A. Cadirni, A. Montagnani, C. Pieropan, S. Campagna, B. Franci, B. Lucani, S. Gonnelli, R. Nuti ................................................. 334
COMPARISON BETWEEN DXA AND QUANTITATIVE ULTRASOUND MEASUREMENTS AT CORTICAL SITES 
DURING TERIPARATIDE TREATMENT
V. Camozzi, F. de Terlizzi, P. Nalin, M. Zangari, L. Moro, G. Luisetto.................................................................................................................... 336
OPG AND RANKL ARE RELATED TO HYPOTALAMUS / HYPOFISIS / GONADAL AXIS IN ELDERLY SUBJECTS
E. Cappellin, R. Gatti, P. Spinella, G. Soldà, G. Antonelli, G. Crepaldi, E.F. De Palo ........................................................................................... 338
INFLUENCE OF A1330V LRP5 GENE POLYMORPHISM ON VOLUMETRIC BMD AND STRUCTURAL PARAMETERS 
OF BONE IN MEN AND WOMEN
C. Cepollaro, F. Lauretani, A. Gozzini, L. Masi, A. Falchetti, F. Del Monte, S. Carbonell-Sala, G. Leoncini, A. Tanini, A.M. Corsi, 
S. Bandinelli, M.L. Brandi ........................................................................................................................................................................................ 340
VITAMIN D RECEPTOR-MEDIATED SUPPRESSION OF DKK1 AND SFRP2 INHIBITS ADIPOGENIC DIFFERENTIATION 
OF BONE MARROW STROMAL CELLS
L. Cianferotti, M.B. Demay........................................................................................................................................................................................ 341
ICARO STUDY (INCIDENCE AND CHARACTERIZATION OF “INADEQUATE TREATMENT RESPONDER PATIENTS” 
IN OSTEOPOROSIS): RESULTS AT ONE-YEAR FOLLOW-UP
M. D’Amore, G. Perpignano, F. Silveri, S. Silvestri, R. Gentilella, A. Bardoscia, A. Nardi..................................................................................... 343
BONE MICROARCHITECTURE OF THE HIP IN OSTEOPOROSIS AND OSTEOARTHRITIS
L. Dalle Carbonare, G. Resmini, C. Redaelli, F. Bertoldo, M.T. Valenti, S. Zenari, M. Zanatta, B. Giovanazzi, S. Giannini, U. Sala, V. Lo Cascio .... 345
MEASUREMENT OF QUALITY OF LIFE (QOL) IN PATIENTS ENROLLED IN THE ICARO STUDY 
(INCIDENCE AND CHARACTERIZATION OF “INADEQUATE TREATMENT RESPONDER PATIENTS” IN OSTEOPOROSIS): 
RESULTS AT FOLLOW-UP AFTER 12 MONTHS 
L. Dalle Carbonare, F.P. Cantatore, G. Lentini, S. Silvestri, R. Gentilella, G. D’Avola, V. Lucchese .................................................................... 347
THE RISK OF FRACTURES IN POSTMENOPAUSAL WOMEN WITH PRIMARY HYPERPARATHYROIDISM
S. De Geronimo, E. Romagnoli, D. Diacinti, S. Piemonte, M.L. Mascia, F. Fidanza, J. Pepe, F. Colapietro, V. Baldini, V. Carnevale, 
A. Scillitani, E. D’Erasmo, S. Minisola ..................................................................................................................................................................... 349
IDENTIFICATION OF SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs) CONTRIBUTING TO BONE MINERAL DENSITY 
AND FRACTURES: A DNA MICROARRAY-BASED STUDY
V. De Paola, L. Gennari, D. Tejedor, D. Merlotti, A. Cadaval, G. Martini, F. Valleggi, M.B. Franci, S. Campagna, B. Lucani, L. Simon, 
A. Martinez, R. Nuti ................................................................................................................................................................................................... 351
EFFECTS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ (PPAR-γ) POLYMORPHISMS ON BONE MASS 
AND FRACTURE RISK 
V. De Paola, L. Gennari, D. Merlotti, G. Martini, F. Valleggi, M.B. Franci, S. Campagna, A. Avanzati, B. Lucani, S. Gonnelli, R. Nuti ............. 353
ECTOPIC PARATHYROID ADENOMA PRIMARY HYPERPARATHYROIDISM (EPAPH)
P. De Remigis, R. Cotellese, P. Ranieri, A. De Remigis, L. Vianale, F. Francomano .............................................................................................. 354
SERUM 25-OH VITAMIN D3 IN RHEUMATIC PATIENTS
A. Delle Sedie, L. Giori, M. Mazzantini, E. Catarsi, A. Tavoni, A. d’Ascanio, O. Di Munno ................................................................................... 355
TERIPERATIDE REIMBURSEMENT IN A SAMPLE OF 200 OLDER WOMEN WITH HIP FRACTURE
M. Di Monaco, F. Vallero, R. Di Monaco, R. Tappero, A. Cavanna ........................................................................................................................ 356
FAT, SKELETAL MUSCLE, AND HIP BONE MINERAL DENSITY IN ELDERLY WOMEN WITH HIP FRACTURE
M. Di Monaco, F. Vallero, R. Di Monaco, R. Tappero, A. Cavanna ........................................................................................................................ 357
BONE MINERAL DENSITY IN PATIENTS WITH PARKINSON’S DISEASE WHO SUSTAINED A HIP FRACTURE: 
A CASE CONTROL STUDY
M. Di Monaco, F. Vallero, R. Di Monaco, R. Tappero, A. Cavanna ........................................................................................................................ 358
SEASONAL VARIATIONS OF VITAMIN D AND PARATHYROID HORMONE: EFFECTS OF AGE AND SEX
V. Fassino, E. Romagnoli, E. D’Erasmo, S. Piemonte, M.L. Mascia, F. Fidanza, J. Pepe, F. Colapietro, V. Baldini, 
V. Carnevale, A. Scillitani, S. Minisola ..................................................................................................................................................................... 359
214
Continued from page 213
215
QUANTITATIVE ULTRASOUND IN ADULTS WITH CYSTIC FIBROSIS: CORRELATION WITH BONE MINERAL DENSITY 
AND RISK OF VERTEBRAL FRACTURES
E. Fracassi, O. Viapiana, L. Idolazzi, M. Rossini, D. Gatti, L. Ambrogi, C. Pompermaier, F. de Terlizzi, S. Adami .............................................. 361
TERIPARATIDE THERAPY IN WOMEN WITH OSTEOPOROSIS AND MULTIPLE INSUFFICIENCY FRACTURES
S. Frigelli, N. Pipitone, M.G. Catanoso, P. Macchioni, G. Bajocchi, L. Boiardi, F. Rossi, G. Restuccia, A. Ghinoi, C. Salvarani ........................ 362
COORDINATION IN THE FIELD OF OSTEOPOROSIS BETWEEN GENERALISTS AND SPECIALISTS: 
THE EXPERIENCE OF THE ASL 17
B. Fruttero, C. Besso, R. Formaggio, C. Giachino, E. Pedini, P. Milano ................................................................................................................. 363
HIGH PREVALENCE OF MORPHOMETRIC AND CLINICAL FRACTURES IN MALE ALCOHOLIC SUBJECTS: 
DISSOCIATION FROM BONE MINERAL DENSITY
C. Ghidini, L. Galantino, M. Pedrazzoni ................................................................................................................................................................... 364
PREDICTORS OF BONE MINERAL DENSITY IN WOMEN WITH PRIMARY HYPERPARATHYROIDISM 
L. Gianotti, F. Tassone, A. Pia, P. Razzore, F. Cesario, G. Magro, G. Borretta ...................................................................................................... 365
PRIMARY HYPERPARATHYROIDISM AND BREAST CANCER
E. Giustarini, A. Pinchera, E. Fiore, P. Fierabracci, I. Muller, E. Vignali, C. Giani............................................................................................... 366
EFFECTS OF A NUTRITIONAL REHABILITATION PROGRAM ON BONE MINERAL DENSITY AND BONE TURNOVER 
IN WOMEN WITH ANOREXIA NERVOSA
L. Idolazzi, O. Viapiana, E. Fracassi, V. Braga, D. Gatti, M. Rossini, R. Dalle Grave, T. Todesco, S. Adami ....................................................... 368
PATIENTS PREFER PROVEN EFFICACY OVER DOSING REGIMEN IN OSTEOPOROSIS THERAPY WITH BISPHOSPHONATES 
G. Iolascon, F. Gimigliano ........................................................................................................................................................................................ 369
STABLE CELL LINES EXPRESSING CALCIUM SENSING RECEPTOR (CaR): 
A TOOL TO DETECT AUTOANTIBODIES TO THE CaR 
M. Lemmi, S. Borsari, E. Pardi, C. Banti, E. Ambrogini, A. Pinchera, C. Marcocci, F. Cetani............................................................................... 370
THE microRNA miR-26a TARGETS THE SMAD1 PROTEIN DURING OSTEOBLASTS DIFFERENTIATION
E. Luzi, F. Marini, S. Carbonell Sala, I. Tognarini, G. Galli, A. Gozzini, M.L. Brandi............................................................................................ 371
USE OF MORPHOEXPRESS IN THE CLINICAL PRACTICE ON BONE METABOLISM: EXPERIENCE FROM 250 CASES
U. Massafra, F. Vacca, E. Mascheroni, M. Diaco, A. Capuano, A. Migliore ........................................................................................................... 372
LONG TERM FOLLOW UP AFTER VERTEBROPLASTY
M. Mazzantini, P. Carpeggiani, V. Iacopetti, A. d’Ascanio, S. Bombardieri, O. Di Munno ..................................................................................... 373
THE EFFECT OF CYCLOSPORINE A ON BONE DENSITY IN FEMALE RHEUMATOID ARTHRITIS PATIENTS: 
RESULTS FROM A MULTICENTER, CROSS-SECTIONAL STUDY
M. Mazzantini, O. Di Munno, L. Sinigaglia, G. Bianchi,M. Rossini, Q. Mela, A. Del Puente, B. Frediani, F. Cantatore, S. Adami ...................... 375
INCIDENCE OF ADVERSE EFFECTS DURING LONG-TERM, LOW-DOSE GLUCOCORTICOID TREATMENT 
OF RHEUMATOID ARTHRITIS
M. Mazzantini, M. Cazzato, R. Talarico, A. Consensi, M. Doveri, R. Neri, S. Bombardieri..................................................................................... 376
EFFECTS OF THERAPY WITH ZOLEDRONIC ACID IN MULTIPLE MYELOMA 
D. Merlotti, G. Martini, A. Gozzetti, S. Salvadori, L. Gennari, A. Avanzati, B. Franci, M.S. Campagna, F. Valleggi, 
V. De Paola, F. Lauria, R. Nuti ................................................................................................................................................................................. 378
THERAPEUTIC EFFECTS OF ZOLEDRONATE OR NERIDRONATE I.V. IN PAGETIC PATIENTS 
NON-RESPONDERS TO PAMIDRONATE
D. Merlotti, L. Gennari, G. Martini, F. Valleggi, V. De Paola, A. Avanzati, S. Campagna, B. Franci, R. Nuti....................................................... 379
OSTEOPOROSIS AND CORTICOSTEROID THERAPY IN RHEUMATOID ARTHRITIS
L. Montaldo, M. Pintus, G. Frongia, R.M. Murgia, C. Contu, Q. Mela .................................................................................................................... 381
EFFECTS OF STRONTIUM RANELATE ON SERUM LEVELS OF IGF-1 IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
N. Morabito, A. Lasco, L. Sottile, A. Catalano, A. Gaudio, D. Maisano, I. Macrì, A. Xourafa, T. Mesiti, E. Morini, G. Giorgianni, N. Frisina............ 383
HIGH CLINICAL SEVERITY OF PAGET’S DISEASE OF BONE IN CAMPANIA, SOUTHERN ITALY
G. Mossetti, L. Gennari, D. Rendina, D. Merlotti, G. De Filippo, G. Zampa, G. Martini, R. Nuti, P. Strazzullo .................................................... 384
RELATIONSHIP BETWEEN METABOLIC SYNDROME AND NEPHROLITHIASIS IN A COHORT OF CAUCASIAN SUBJECTS 
FROM SOUTHERN ITALY
G. Mossetti, D. Rendina, G. De Filippo, D. Benvenuto, C.L. Vivona, S. Ricchio, P. Strazzullo ............................................................................... 386
RETROSPECTIVE SURVEY BETWEEN ACTIVE LIFE STYLE AND BONE DENSITY
F. Muratore, G. Russo, L. Fedeli, F. Cacciola, M. Veca, G. Gravante, E. Faldetta, V. Viviano, M. Chinnici ......................................................... 388
see page 220
QUANTITATIVE ULTRASOUND AT THE PHALANGES IN MONITORING ALENDRONATE TREATMENT
M.G. Nicolosi, M. Campogrande, R. Grio ................................................................................................................................................................. 390
DIFFERENT PREVALENCE OF FRACTURES IN WOMEN WITH A HISTORY OF EARLY VS LATE MATERNAL HIP FRACTURE
M. Pedrazzoni, C. Campanini, G. Passeri, C. Ghidini, P. Sansoni ........................................................................................................................... 391
ASSOCIATION OF HIGH ALPHA2-HEREMANS- SCHMID GLYCOPROTEIN/FETUIN CONCENTRATION IN SERUM 
AND INTIMA-MEDIA THICKNESS (IMT) IN PATIENTS WITH ATHEROSCLEROTIC VASCULAR DISEASE AND LOW BONE MASS
P. Pennisi, S.S. Signorelli, G. Celotta, F. Santoro, N. Parisi, L. Privitelli, Z. Castelli, R.A. Mangiafico, C.E. Fiore .............................................. 392
APPRAISAL OF THE CORTICAL INDEX IN PATIENT WITH PRIMITIVE HYPERPARATHYROIDISM
N. Piolanti, S. Marchetti, G. Viccica, E. Vignali, C. Baggiani, A. Faldini................................................................................................................ 393
SECONDARY HYPERPARATHYROIDISM DECREASES THE BENEFICIAL EFFECT OF ALENDRONATE 
ON BONE MINERAL DENSITY IN OSTEOPOROTIC WOMEN
G. Pioli, A. Barone, G. Girasole, A. Giusti, M. Pizzonia, M. Razzano, V. Siccardi, E. Palummeri, G. Bianchi ...................................................... 394
INCIDENCE AND COSTS OF HIP FRACTURES IN ITALY BETWEEN 1999 AND 2003
P. Piscitelli, G. Iolascon, R. Gimigliano, G. Guida, A. Angeli, M. Rossini, S. Adami, A. Distante .......................................................................... 396
EFFECTS OF TITANIUM SURFACE TOPOGRAPHY ON THE BIOLOGICAL BEHAVIOUR OF HUMAN GINGIVAL FIBROBLASTS 
L. Postiglione, G. Di Spigna, R. Saviano, A.E. di Lauro, G. Rossi, L. Ramaglia ...................................................................................................... 398
LOSS OF BONE MINERAL DENSITY AND SECONDARY HYPERPARATHYROIDISM ARE COMPLICATIONS 
OF AUTOLOGOUS STEM CELL TRANSPLANTATION
A.M. Scarponi, R. Ria, F. Falzetti, M. Di Ianni, S. Ballanti, G. Fabbriciani, C. Leli, M. Brozzetti, A. Tabilio, E. Mannarino ............................... 399
CLINICAL SIGNIFICANCE OF ACTIVIN A SERUM LEVELS IN PATIENTS WITH PRIMARY OSTEOPOROSIS: 
A PRELIMINARY REPORT
C. Sferrazza, G. Di Fede, L. Incorvaia, G. Badalamenti, N. Gebbia, G.B. Rini, G. Leto ......................................................................................... 401
COLIA1 POLYMORPHISM AND BONE MASS IN AN ELDERLY POPULATION
F. Silva-Netto, E. Musacchio, E. Perissinotto, E. Manzato, G. Baggio, S. Zambon, M.C. Corti, G. Crepaldi, G. Realdi, L. Sartori ...................... 402
THE EFFECTS OF ESTROGEN RECEPTORS AND AROMATASE GENE POLYMORPHISMS ON BONE MINERAL DENSITY, 
LIPID PROFILE AND THE RESPONSE TO HORMONE REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN
S. Silvestri, A. Bloch Thomsen, A. Gozzini, C. Christiansen, M.L. Brandi ................................................................................................................ 404
DEXA AND QUS IN PREMENOPAUSAL PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
C. Tani, C. Neri, M. Mazzantini, A. Delle Sedie, M. Mosca, S. Bombardieri, O. Di Munno .................................................................................... 405
BONE MASS IN LONG-TERM SURVIVORS AFTER ALLOGENEIC OR AUTOLOGOUS STEM CELL TRANSPLANTATION
L. Tauchmanovà, A. Rusciano, M.C. Savanelli, M. Galdiero, G. De Rosa, V. Ramundo, G. Lombardi, B. Rotoli, A. Colao, C. Selleri ................. 407
TERIPARATIDE INCREASES SERUM FIBROBLAST GROWTH FACTOR 23 IN OSTEOPOROTIC WOMEN
F. Valleggi, G. Martini, S. Gonnelli, L. Gennari, S. Salvadori, C. Caffarelli, B. Franci, M.S. Campagna, A. Avanzati, 
D. Merlotti, V. De Paola, R. Nuti .............................................................................................................................................................................. 409
CIRCULATING OPG, RANKL, AND CATHEPSIN K LEVELS BEFORE AND AFTER INTRAVENOUS BISPHOSPHONATE 
TREATMENT IN PAGET’S DISEASE OF BONE
F. Valleggi, L. Gennari, G. Martini, D. Merlotti, V. De Paola, S. Salvadori, A. Avanzati, B. Franci, S. Campagna, R. Nuti ................................ 411
OSTEOPOROSIS AND NON-INSULIN-DEPENDENT DIABETES MELLITUS: PATHOGENETIC ROLE 
OF A LOW DIETARY CALCIUM INTAKE
M. Varenna, L. Binelli, A.M.P. Lurati, D. Mazzocchi, L. Sinigaglia ......................................................................................................................... 413
CALCIUM-SENSING RECEPTOR (CaSR):A CANDIDATE-GENE FOR CALCIUM KIDNEY STONE DISEASE
G. Vezzoli, T. Arcidiacono, A. Terranegra, R. Biasion, V. Paloschi, G. Gambaro, A. D’Angelo, M.L. Brandi, A. Tanini, A. Falchetti, 
E. Croppi, R. Caudarella, A. Trinchieri, P. Strazzullo, G. Mossetti, L. Borghi, F. Macciardi, D. Cusi, L. Soldati ................................................. 414
PATIENTS WITH OSTEOPOROTIC VERTEBRAL FRACTURES: EFFECT OF CAPACITIVELY COUPLED ELECTRIC FIELD 
ON PAIN RELEASE
O. Viapiana, L. Idolazzi, E. Fracassi, M. Rossini, D. Gatti, A. Zambito, D. Bianchini, F. de Terlizzi, S. Adami..................................................... 416
VERTEBRAL FRACTURE ASSESSMENT BY MORPHOMETRIC X-RAY ABSORPTIOMETRY 
IN PRIMARY HYPERPARATHYROIDISM
G. Viccica, E. Vignali, D. Diacinti, R. Del Fiacco, L. Cianferotti, F. Cetani, A. Picone, E. Ambrogini, C. Banti, A. Pinchera, C. Marcocci ........ 418
EFFECTS OF TERIPARATIDE AND ALENDRONATE ON BMD AND BIOMECHANICAL CHARACTERISTICS 
OF THE HIP IN POSTMENOPAUSAL OSTEOPOROSIS
M. Zanatta, F. Bertoldo, L. Dalle Carbonare, S. Zenari, B. Giovanazzi, M.T. Valenti, V. Lo Cascio ...................................................................... 420
Authors’ index ................................................................................................................................................................................................... 423
216
Continued from page 217
